Ocular Evidence
Community experiences

What people report after refractive surgery

Search structured details from individual public forum accounts. These are anecdotes, not clinical evidence or estimates of how often an outcome occurs.

Read this layer differently from study results. Posts are self-reported, selectively shared and may be incomplete or inaccurate. We never combine them into complication, satisfaction or success rates.
Reset

202 reviewed experiences

Only curator-approved records with a currently verified source appear here. No usernames or copied post bodies are published.

Self-reported anecdoteMixed report

ICL experience · 2024

A detailed EVO+ toric ICL diary reported 20/15 right-eye and 20/20 left-eye acuity at four weeks. Temporary blur when moving into darkness, peripheral halos and reduced near vision persisted, but night driving remained functional.

Device
EVO+ Visian Toric ICL

Reported starting point

Sphere-8 D
Right eye · stated by poster
Sphere-7.5 D
Left eye · stated by poster
Astigmatism2 D
Both eyes · stated by poster

Reported results and symptoms

Visual acuity20/15
Right eye · 4 weeks · stated by poster
Visual acuity20/20
Left eye · 4 weeks · stated by poster
Eye pressure17 mmHg
Both eyes · 4 weeks · stated by poster
Residual visual effectsBrief dark-adaptation blur, some peripheral halos and strained near vision
Both eyes · 2 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account at 8 months described the result. Topics included dry eye, glare, light sensitivity. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 8 months · stated by poster
Symptoms discusseddry eye, glare, light sensitivity
Both eyes · 8 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account at 1 day described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, ghosting, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-6.25 D, -1.5 D, -7.75 D, -1.75 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 day · stated by poster
Reported visual-acuity values20/20
1 day · stated by poster
Symptoms discussedhalos, ghosting, blur or fluctuating vision, pain or discomfort
Both eyes · 1 day · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account at 2.5 months described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15, 20/12. Topics included dry eye, halos, glare, ghosting. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-0.25 D, -0.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2.5 months · stated by poster
Reported visual-acuity values20/20, 20/15, 20/12
2.5 months · stated by poster
Symptoms discusseddry eye, halos, glare, ghosting, double vision, blur or fluctuating vision
Both eyes · 2.5 months · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, blur or fluctuating vision, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Age
25
Device
Visian ICL

Reported starting point

Reported prescription values-11.25 D, -11.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account at 2 weeks described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included dry eye, double vision, blur or fluctuating vision, haze. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-7 D, -6.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 weeks · stated by poster
Reported visual-acuity values20/20
2 weeks · stated by poster
Symptoms discusseddry eye, double vision, blur or fluctuating vision, haze, light sensitivity, pain or discomfort
Both eyes · 2 weeks · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2024

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included ghosting, pain or discomfort. The source did not state a clear overall satisfaction judgment.

Reported starting point

Reported prescription values-2.5 D
stated by poster
Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedghosting, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, glare, ghosting, blur or fluctuating vision. The poster's overall assessment was favorable.

Age
30

Reported starting point

Reported prescription values-7 D, -8 D, -1 D, -1.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, glare, ghosting, blur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2024

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included halos, haze, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, haze, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2023

A first-person ICL account at 2 weeks described the result. The source included baseline prescription values. Topics included halos, ghosting, blur or fluctuating vision, night-vision difficulty. The poster described a mixed result or a recovery with meaningful tradeoffs.

Device
EVO ICL

Reported starting point

Reported prescription values-10.5 D, -9.5 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 weeks · stated by poster
Symptoms discussedhalos, ghosting, blur or fluctuating vision, night-vision difficulty
Both eyes · 2 weeks · stated by poster
Self-reported anecdoteMixed report

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 6/6. Topics included halos, starbursts, ghosting, night-vision difficulty. The poster described a mixed result or a recovery with meaningful tradeoffs.

Device
Visian ICL

Reported starting point

Reported prescription values-4.25 D
stated by poster
Overall self-assessmentmixed
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values6/6
Follow-up reported · stated by poster
Symptoms discussedhalos, starbursts, ghosting, night-vision difficulty
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2008

A first-person ICL account at 15 years described the result. Reported acuity included 20/20. Topics included halos. The poster's overall assessment was favorable.

Device
Visian ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 15 years · stated by poster
Reported visual-acuity values20/20
15 years · stated by poster
Symptoms discussedhalos
Both eyes · 15 years · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account at 2 weeks described the result. The source included baseline prescription values. Reported acuity included 20/20, 6/6. Topics included halos, ghosting, haze, light sensitivity. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-7 D, -8 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 2 weeks · stated by poster
Reported visual-acuity values20/20, 6/6
2 weeks · stated by poster
Symptoms discussedhalos, ghosting, haze, light sensitivity, pain or discomfort, floaters
Both eyes · 2 weeks · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included halos, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Age
31
Device
EVO ICL

Reported starting point

Reported prescription values-9.5 D, -8.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedhalos, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account at 3 weeks described the result. The source included baseline prescription values. Topics included blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-14 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 3 weeks · stated by poster
Symptoms discussedblur or fluctuating vision, pain or discomfort
Both eyes · 3 weeks · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account at 1 day described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included halos, ghosting, blur or fluctuating vision, haze. The poster's overall assessment was favorable.

Device
EVO ICL

Reported starting point

Reported prescription values-10 D, -7.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 day · stated by poster
Reported visual-acuity values20/20, 20/15
1 day · stated by poster
Symptoms discussedhalos, ghosting, blur or fluctuating vision, haze, light sensitivity, pain or discomfort
Both eyes · 1 day · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account at 1 week described the result. The source included baseline prescription values. Topics included halos, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-7.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 week · stated by poster
Symptoms discussedhalos, light sensitivity, pain or discomfort
Both eyes · 1 week · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included halos, blur or fluctuating vision, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.

Age
28
Device
EVO ICL

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, light sensitivity, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. Reported acuity included 20/20, 20/15. Topics included halos, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.

Reported starting point

Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/15
Follow-up reported · stated by poster
Symptoms discussedhalos, blur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included starbursts, double vision, blur or fluctuating vision. The poster's overall assessment was favorable.

Age
30
Device
EVO ICL

Reported starting point

Reported prescription values-11 D, -9 D, -6 D, -5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/15
Follow-up reported · stated by poster
Symptoms discussedstarbursts, double vision, blur or fluctuating vision
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported dissatisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/30, 20/40, 20/15. Topics included dry eye, halos, double vision, blur or fluctuating vision. The poster's overall assessment was unfavorable.

Age
28

Reported starting point

Reported prescription values-5 D, -3 D, -8.5 D, -10 D
stated by poster
Overall self-assessmentunsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/30, 20/40, 20/15
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, double vision, blur or fluctuating vision, haze, night-vision difficulty, pain or discomfort, floaters
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/40. Topics included glare, blur or fluctuating vision. The source did not state a clear overall satisfaction judgment.

Device
EVO ICL

Reported starting point

Reported prescription values-14 D
stated by poster
Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/20, 20/40
Follow-up reported · stated by poster
Symptoms discussedglare, blur or fluctuating vision
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included halos, glare, ghosting, pain or discomfort. The poster's overall assessment was favorable.

Age
30

Reported starting point

Reported prescription values-11 D, -11.5 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Symptoms discussedhalos, glare, ghosting, pain or discomfort
Both eyes · Follow-up reported · stated by poster
Self-reported anecdoteSentiment unclear

ICL experience · 2023

A first-person ICL account at 1 month described the result. Topics included halos. The source did not state a clear overall satisfaction judgment.

Device
Visian ICL

Reported starting point

Overall self-assessmentunclear
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · 1 month · stated by poster
Symptoms discussedhalos
Both eyes · 1 month · stated by poster
Self-reported anecdoteReported satisfied

ICL experience · 2023

A first-person ICL account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/40, 20/30, 20/15, 20/20. Topics included dry eye, halos, ghosting, blur or fluctuating vision. The poster's overall assessment was favorable.

Reported starting point

Reported prescription values-8.5 D, -1.75 D
stated by poster
Overall self-assessmentsatisfied
Both eyes · curator inference

Reported results and symptoms

Follow-up pointPostoperative experience reported
Both eyes · Follow-up reported · stated by poster
Reported visual-acuity values20/40, 20/30, 20/15, 20/20
Follow-up reported · stated by poster
Symptoms discusseddry eye, halos, ghosting, blur or fluctuating vision, pain or discomfort
Both eyes · Follow-up reported · stated by poster